Stem Cell Blog
Second HIV patient cured with stem cell treatment
In an exciting new development within the stem cell field, a man from London has become the second patient in the world to be cured of HIV following a stem cell treatment. Alongside being diagnosed with HIV in 2003, Adam Castillejo was also later diagnosed with...
The Race for a Cure: an oral COVID-19 vaccine
Last week, Cells4Life's sister company, Stabilitech, featured on ITV's Tonight programme "The Race for a Cure: Making Britain Safer". This episode looks at making a COVID-19 vaccine. You can watch the full interview by watching the video below. Request a Welcome Pack...
Stabilitech, Recognised by WHO as COVID-19 Vaccine Developer
The sister company of Cells4Life, Stabilitech Biopharma, have been formally recognised by the World Health Organisation (WHO) as an official vaccine developer. Stabilitech board member Dr Jeff Drew, who is also the co-founder of Cells4Life, noted: “The WHO is a...
Study: Pregnancy Not Increasing Severe COVID-19 Risk
According to the first large-scale study of its kind, pregnant women are at no greater risk of being admitted to hospital with severe coronavirus symptoms than other women. The study examined more than 420 expectant mothers who were admitted to hospital with critical...
Stabilitech Joins Race for COVID-19 Vaccine
The sister company of Cells4Life – Stabilitech – has joined the race to create a vaccine for the coronavirus which has put the country into lockdown and is currently raising £6 million in funding to finance the next crucial stage of development.Stabilitech, a UK...
Find out more, request your welcome pack today
Discover all you need to know to make an informed decision.
Provide your contact details to request:
– Complete Welcome Pack and Parent’s Guide
– Information via email
– Contact from our specialist advisors
Find out more, request your welcome pack today
Discover all you need to know to make an informed decision.
Provide your contact details to request:
– Complete Welcome Pack and Parent’s Guide
– Information via email
– Contact from our specialist advisors

